At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 22 enrolled
Drug / intervention
donepezil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults: A Pilot Study
In Brief
A Phase 4 clinical trial evaluating donepezil and Placebo (cornstarch) for Mental Health and Geriatrics. Completed, enrolled 22 participants across 2 sites.
Detailed Summary
The goal of the study is to assess the role of cholinesterase inhibitors in affecting the driving ability of cognitively intact seniors using driving simulators. We hypothesize that the use of a cholinesterase inhibitor for two weeks will be associated with improvement in safe driving behavior on a simulated driving task.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMental Health, Geriatrics
CountriesCanada
CollaboratorsUniversity of Toronto
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2007
First PostedJun 2007
Primary CompletionAug 2008
TodayJul 2026
First PostedJun 4, 2007
Enrollment StartJun 1, 2007
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 19.1 years ago
Interventions
donepezildrug
Placebo (cornstarch)drug